Related Experiment Videos

Progressive cardiomyopathic lentiginosis: report of six cases and one autopsy

Pediatric Dermatology
|October 1, 1983
PubMed

Insights

Progressive cardiomyopathic lentiginosis (PCL) is a rare syndrome characterized by skin spots and heart problems. Early diagnosis in children relies on identifying lentigines, cardiac defects, and ECG changes.

Area of Science:

  • Genetics and rare diseases
  • Cardiology
  • Dermatology

Background:

  • Progressive cardiomyopathic lentiginosis (PCL) is a rare genetic disorder.
  • It presents with multisystem abnormalities, often including cardiac and cutaneous manifestations.
  • Lentigines are a key diagnostic feature, typically appearing early in life.

Purpose of the Study:

  • To describe the clinical features of Progressive cardiomyopathic lentiginosis (PCL) in a pediatric cohort.
  • To highlight the most consistent diagnostic markers for PCL in children.
  • To aid in the early identification and management of PCL.

Main Methods:

  • Retrospective case series.
  • Clinical data collection from six pediatric patients diagnosed with PCL.
  • Analysis of presenting signs and symptoms, including dermatological, cardiac, and other systemic findings.

Main Results:

  • The most consistent findings in children with PCL were multiple cutaneous lentigines, structural cardiac anomalies, and electrocardiographic alterations.
  • Less frequent manifestations included neurosensory deafness, short stature, and abnormalities of the bones, eyes, and genitourinary system.
  • Lentigines were identified as a crucial early diagnostic indicator.

Conclusions:

  • Early recognition of PCL in children is facilitated by the presence of lentigines, cardiac abnormalities, and ECG changes.
  • PCL is a complex syndrome requiring a multidisciplinary approach for comprehensive patient care.
  • Further research is needed to understand the long-term prognosis and management strategies for PCL.

Related Concept Videos